It’s a wild day in the Indian stock market on the eve of April Futures & Options (F&O) series expiry, with major indices swinging up and down. But amidst this turbulence, there’s one sector standing tall—Nifty Pharma. The pharma index has edged up by 0.42%, and one stock that’s caught everyone’s attention is Divis Laboratories …